JADE101 Phase 1 healthy volunteer trial ongoing; biomarker-rich interim data expected in the first half of 2026 Phase 2 clinical trial of JADE101 ...

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "The Development of Therapeutic Monoclonal Antibody Products" report to their offering. "The Development of Therapeutic ...

Researchers in the United States have demonstrated the potential of a monoclonal antibody to inform the design of pan-coronavirus vaccines that could prevent the outbreak of future pandemics such as ...

TOKYO--(BUSINESS WIRE)--FUJIFILM Corporation (President: Kenji Sukeno) is to invest a total of 3.2 billion yen on its CDMO *1 sites in the U.S.A. and the U.K. in order to accelerate the expansion of ...

In addition to DNA sequence information, site-specific histone modifications are another important determinant of gene expression in a eukaryotic organism. We selected four modification sites in ...

In a recent study published in the Molecular Therapy journal, researchers explored strategies for developing effective monoclonal antibodies (mAbs) against severe acute respiratory syndrome ...

Want to share this FREE webinar with a colleague? Fill out the form below and we'll send your colleague an invitation to the "Strategies To Streamline Monoclonal Antibody Development "event. Ensuring ...

Monoclonal antibody (mAb) is generated from a single clone of an antibody-producing cell and recognizes one specific epitope. It has been known for its advantages of high specificity, sensitivity, ...

BioProcess Technology Consultants, Inc. announces publication of The Development of Therapeutic Monoclonal Antibody Products, a 334-page comprehensive review and analysis of the Chemistry, ...

A study published in Nature Medicine examines a monoclonal antibody isolated from the blood of individuals vaccinated for malaria and its potential role in preventing infection from tropical diseases.

The US Food and Drug Administration has granted priority review to lecanemab, an antibody intended to treat Alzheimer’s disease by dissolving amyloid plaques in the brain. Lecanemab marks another ...

Advances in our understanding of the pathogenesis of rheumatic diseases such as rheumatoid arthritis and systemic lupus erythematosus have led to the emergence of immunoglobulin-based therapy as a ...